MassMutual Private Wealth & Trust’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-75
Closed -$611 2467
2026
Q1
$611 Buy
+75
New +$680 ﹤0.01% 2202
2025
Q4
Sell
-148
Closed -$1.28K 2431
2025
Q3
$1.28K Buy
+148
New +$1.15K ﹤0.01% 2100
2025
Q2
Sell
-81
Closed -$519 2453
2025
Q1
$519 Buy
+81
New +$670 ﹤0.01% 2226
2024
Q4
Sell
-72
Closed -$909 2342
2024
Q3
$909 Buy
+72
New +$930 ﹤0.01% 1879
2022
Q4
Sell
-53
Closed -$1K 1781
2022
Q3
$1K Buy
+53
New +$2.3K ﹤0.01% 1470
2022
Q1
Sell
-4
Closed -$1K 1602
2021
Q4
$1K Buy
+4
New +$687 ﹤0.01% 1268
2021
Q1
Sell
-100
Closed -$11K 1158
2020
Q4
$11K Buy
+100
New +$10.6K ﹤0.01% 594
2018
Q4
Sell
-34
Closed -$1.26K 1024
2018
Q3
$1.26K Hold
34
﹤0.01% 878
2018
Q2
$902 Hold
34
﹤0.01% 1016
2018
Q1
$1.41K Hold
34
﹤0.01% 891
2017
Q4
$835 Hold
34
﹤0.01% 841
2017
Q3
$767 Hold
34
﹤0.01% 987
2017
Q2
$774 Hold
34
﹤0.01% 950
2017
Q1
$861 Hold
34
﹤0.01% 944
2016
Q4
$848 Buy
+34
New +$992 ﹤0.01% 623
2016
Q2
$4.89K Buy
+34
New +$3.9K ﹤0.01% 574

Other funds holding NVAX

MassMutual Private Wealth & Trust's NVAX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust sold out of Novavax (NVAX) in Q2 2026, closing a stake of 75 shares — an estimated $611 sold.

MassMutual Private Wealth & Trust first reported a position in NVAX in Q2 2016 and held it in 16 quarters. The position peaked at $11K in Q4 2020. 70 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • MassMutual Private Wealth & Trust reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 75 Novavax shares in Q2 2026, an estimated $611.
  • MassMutual Private Wealth & Trust first reported a position in Novavax in Q2 2016 and held it in 16 quarters.
  • MassMutual Private Wealth & Trust's Novavax position peaked at $11K in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.